PRP

BBB National Programs Applauds Today's Launch of the Global CBPR Forum, Strengthening Commitments to International Data Privacy

Retrieved on: 
Tuesday, April 30, 2024
BBB National Programs, CBPR, Certification, Accountability, PRP, Privacy, Senior, Commerce, Trust, Medical device

Dona Fraser, Senior Vice President, Privacy Initiatives, BBB National Programs, underscoring the importance of data privacy for international business operations, said: "In an economy where businesses extend operations across borders, data privacy is the cornerstone of trust and compliance.

Key Points: 
  • Dona Fraser, Senior Vice President, Privacy Initiatives, BBB National Programs, underscoring the importance of data privacy for international business operations, said: "In an economy where businesses extend operations across borders, data privacy is the cornerstone of trust and compliance.
  • BBB National Programs is the sole non-profit Accountability Agent providing CBPR and Privacy Recognition for Processors (PRP) certifications, serving to assist companies with a commitment to global privacy.
  • BBB National Programs also provides privacy compliance for vendors aligned to the standards, strengthening the focus on robust third-party risk management.
  • Both certifications – CBPR for data controllers and PRP for data processors– are backed by BBB National Programs' independent accountability for privacy best practices.

Gaxos Health Expands Medical Advisory Board

Retrieved on: 
Thursday, April 25, 2024
Physical medicine and rehabilitation, Johns Hopkins University, Health care, Sport, Abstract, Testosterone, Private practice, MD, Columbia University, PRP, Intelligence, New York (magazine), Prostate cancer, Erectile dysfunction, Cornell University, Drug, Spine, Patient, Bachelor of Arts, Rehabilitation, Public key certificate, Seton Hall University, Medical Center, Hormone replacement therapy, Injury, Partner, Medical device

Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.

Key Points: 
  • Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.
  • “The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health,” said Vadim Mats, CEO of Gaxos.AI.
  • “An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders.”
    Dr. Eric Margolis, M.D.
  • “We welcome Dr. Margolis and Dr. Pavell to the advisory board as their experience and insight will allow us to create a more fine-tuned solution,” Vadim Mats added.

Renowned Functional Medicine and Anti-Aging Practice Announces Expansion

Retrieved on: 
Tuesday, April 30, 2024
Pain, Acupuncture, Health, Human, PRP, Hair loss, Pain management, Patient, Headache, Medicine, Trust, Regenerative medicine, Toxicity, Beauty, Ageing, Longevity, Injection, Medical imaging

NEW YORK, April 30, 2024 /PRNewswire-PRWeb/ -- Dr. Alexander Golberg, board-certified in family medicine, osteopathic, anti-aging, and regenerative medicine, is proud to announce the opening of a new flagship location at 910 Park Avenue in Manhattan. Dr. Golberg established his practice in Brooklyn 25 years ago and is renowned for his natural, whole-person approach to pain management and anti-aging rooted in the philosophies of functional medicine.

Key Points: 
  • NEW YORK, April 30, 2024 /PRNewswire-PRWeb/ -- Dr. Alexander Golberg, board-certified in family medicine, osteopathic, anti-aging, and regenerative medicine, is proud to announce the opening of a new flagship location at 910 Park Avenue in Manhattan.
  • Dr. Golberg established his practice in Brooklyn 25 years ago and is renowned for his natural, whole-person approach to pain management and anti-aging rooted in the philosophies of functional medicine.
  • This state-of-the-art medical facility embodies beauty and function, mirroring Dr. Golberg's medical philosophy, and will offer expanded services and capabilities to provide complete, patient-centered functional medicine and aesthetic services that treat the whole person.
  • He's embraced a concierge approach to medicine, which he credits with enabling him to build the trust in patient relationships needed to treat their most pressing symptoms.

Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office

Retrieved on: 
Tuesday, April 16, 2024
Research, General Health, Pharmaceutical, Oncology, Hospitals, Genetics, Clinical Trials, Science, Surgery, Biotechnology, FDA, Health, IP, Trypsinogen, European Patent Convention, Chymotrypsinogen, EFPIA, United States of Europe, Statista, PRP, Patent, Patient, OTC Markets Group, PPCB, Pharmaceutical industry

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s “composition of proenzymes for cancer treatment,” patent was received from the European Patent Office.

Key Points: 
  • Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s “composition of proenzymes for cancer treatment,” patent was received from the European Patent Office.
  • The patent covers lower dosage ratios of the two proenzymes (trypsinogen and chymotrypsinogen) contained in the PRP formulation.
  • This is the fourth European patent granted and after validation in selected countries across Europe, will result in the Company’s IP portfolio growing to 94 patents filed in major global jurisdictions.
  • This is a significant percentage when you consider that in 2022, the worldwide pharmaceutical market was valued at approximately $1.48 trillion by Statista.com.

Profit Recovery Partners, LLC Name Bryan Bellacosa as Vice President, Information Technology

Retrieved on: 
Tuesday, March 19, 2024
Product management, PRP, Senior, Information technology, Fidelity National Financial

SANTA ANA, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Profit Recovery Partners, LLC (PRP) announced today the hire of Bryan Bellacosa as their new Vice President, Information Technology.

Key Points: 
  • SANTA ANA, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Profit Recovery Partners, LLC (PRP) announced today the hire of Bryan Bellacosa as their new Vice President, Information Technology.
  • Before joining PRP, Bryan was the Senior Vice President of Product Management and Information Technology at ServiceLink, where he built technology and innovative processes supporting Title, Escrow, and Default Mortgage Services.
  • Mr. Bellacosa will be replacing Ryan Schlunz, who has served at PRP for 10 years.
  • With 25 years of experience in the information technology space, Bryan is an established leader specializing in digital transformation through the adoption, development, and implementation of industry leading advanced technologies.

CENIC Honors San Diego State University and the San Diego Supercomputer Center for their Roles in Developing the Technology Infrastructure for Data Exploration (TIDE) Project

Retrieved on: 
Tuesday, March 19, 2024
Technology, Software, Networks, Internet, University, Primary, Secondary, Data Management, Education, Artificial Intelligence, CIO, SDSC, Organization, GPU, Artificiality, SDSU, California State University, National Science Foundation, Partnership, California State University, Stanislaus, NRP, UC, Research, CSU, Cyberinfrastructure, Private sector, PRP, Student, Faculty, NSF, TIDE, CENIC, Artificial intelligence, San Diego State University

CENIC is pleased to present the 2024 Innovations in Networking Award for Equitable Access to Cyberinfrastructure to the Technology Infrastructure for Data Exploration (TIDE) Project.

Key Points: 
  • CENIC is pleased to present the 2024 Innovations in Networking Award for Equitable Access to Cyberinfrastructure to the Technology Infrastructure for Data Exploration (TIDE) Project.
  • This new CSU TIDE cyberinfrastructure, which is interconnected and accessed via the CENIC network, is supported by the National Science Foundation (NSF Award #2346701).
  • The project was spearheaded by Jerry Sheehan, now Chief Information Officer at the Salk Institute, during his time as CIO at San Diego State University.
  • (TIDE) exemplifies this springboard approach to innovation by leveraging the CENIC network's robust foundation and our partners' computational expertise at the San Diego Supercomputer Center,” Sheehan stated.

Serotonin Anti-Aging Centers to Debut in Chicagoland with 3-Unit Development Deal

Retrieved on: 
Thursday, March 21, 2024
Health, Collagen induction therapy, Elective surgery, Economic development, Overalls, PRP, Hormone replacement therapy, Happiness, HRT, Day, Map, HBOT, Fast food

CHICAGO, March 21, 2024 /PRNewswire/ -- Serotonin Anti-Aging Centers announced today the upcoming opening of three new locations in the Chicago suburbs. The nation's fastest growing anti-aging/longevity franchise plans to open the doors to its first location in DuPage County within the year.

Key Points: 
  • CHICAGO, March 21, 2024 /PRNewswire/ -- Serotonin Anti-Aging Centers announced today the upcoming opening of three new locations in the Chicago suburbs.
  • When searching for new business opportunities, Aboobaker was drawn toward optimizing the health of Chicagoland residents with the science-backed services of Serotonin.
  • "Awarding this franchise to Pilakka is a fantastic opportunity for the Serotonin brand national footprint," said Eric Casaburi, Founder and CEO of Serotonin Anti-Aging Centers.
  • To learn more about Serotonin Anti-Aging Centers and its franchising opportunities, visit www.serotonincenters.com/franchising/ .

Belden Launches Hirschmann BXP (BOBCAT eXtreme Performance) Managed Switch

Retrieved on: 
Wednesday, February 21, 2024
Telecommunications, Networks, Hardware, Data Management, Rail, Technology, Transport, Semiconductor, BDC, CE, Internet, BXP, Shock, HiOS, Belden Incorporated, REACH, Data-rate units, Vibration, Standard, International Electrotechnical Commission, PRP, Power over Ethernet, IEC, Inc., HSR, Power

Belden Inc. (NYSE: BDC), a leading global supplier of network infrastructure and digitization solutions, today announced the launch of its Hirschmann BXP (BOBCAT eXtreme Performance) managed switch.

Key Points: 
  • Belden Inc. (NYSE: BDC), a leading global supplier of network infrastructure and digitization solutions, today announced the launch of its Hirschmann BXP (BOBCAT eXtreme Performance) managed switch.
  • The BOBCAT managed switch provides powerful benefits, such as:
    High port density, including 20-port and 28-port variants, to connect more network devices.
  • “BXP adds value through simplified web-based configuration, flexible Layer 2 or Layer 3 switch configuration options, and advanced security via the Hirschmann Operating System (HiOS).
  • The BXP has attained multiple international and industry certifications – including Conformité Européenne (CE), International Electrotechnical Commission (IEC), and Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).

Genus plc Reports Interim Results for the Six Months Ended 31 December 2023

Retrieved on: 
Thursday, February 22, 2024
Health, Genetics, Agriculture, Natural Resources, Research, Science, Biotechnology, New product development, PRRS, Traction, Financial statement, ABS, US FDA, Growth, APM, Commercialization, PRP, PIC, PBT, Cropping system, Bank statement, Environment, Fine chemical

Exceptional restructuring costs of £2.9m recognised through the FY24 H1 condensed income statement.

Key Points: 
  • Exceptional restructuring costs of £2.9m recognised through the FY24 H1 condensed income statement.
  • These APMs should be considered in addition to, and not as a substitute for or as superior to statutory measures.
  • Constant currency percentage movements are calculated by restating the results for the six months ended 31 December 2023 at the average exchange rates applied to adjusted operating profit for the year ended 30 June 2023.
  • Please see Note 1 on the notes to the condensed set of Financial Statements changes of reportable segments

Family Dentistry of Frisco Introduces Advanced Dental Implant Solutions with Innovative PRP Technique and Comprehensive Sedation Options

Retrieved on: 
Wednesday, March 6, 2024
Regeneration, DDS, Multimedia, Dentures, Nitrous oxide, Platelet, Dental implant, Quality of life, Overalls, Platelet-rich plasma, Dental, Dental care, Safety, PRP, Patient, Anatomy, Dentistry, Implant

FRISCO, Texas, March 5, 2024 /PRNewswire-PRWeb/ -- Family Dentistry of Frisco, under the esteemed leadership of Dr. Paresh B. Patel, DDS, is proud to announce the expansion of its dental services to include state-of-the-art Dental Implants and Implant Supported Dentures, commonly referred to as All-on-4. These advanced treatments are now enhanced by the innovative use of Platelet-Rich Plasma (PRP) technology, setting a new standard in dental care excellence and patient comfort in the Frisco area.

Key Points: 
  • Family Dentistry of Frisco has proudly announced the introduction of its advanced dental implant solutions, featuring the innovative Platelet-Rich Plasma (PRP) technique and a wide range of comprehensive sedation options.
  • At the forefront of dental technology, Family Dentistry of Frisco incorporates PRP in implant procedures to accelerate healing and improve the success rate of dental implants.
  • Understanding the importance of comfort and ease for our patients, Family Dentistry of Frisco offers multiple levels of sedation dentistry to ensure a calm and pain-free experience during dental implant procedures.
  • The introduction of PRP technology and our comprehensive sedation options exemplify our commitment to pioneering dental treatments that prioritize patient well-being and satisfaction."